Henry L. Mann

Partner

Henry serves as a strategic counselor and pragmatic deal-maker for clients across industries, guiding transactions and solving problems with a focus on practical results.

Henry Mann Portrait

Henry serves as a strategic advisor and pragmatic deal-maker for companies, investors, and family offices. Clients turn to him for judgment, responsiveness, and clear guidance on transactions and ongoing corporate matters across numerous industries.

Henry’s practice centers on mergers and acquisitions, joint ventures, private placements, restructurings, and strategic commercial and licensing arrangements. He also frequently acts as outside general counsel, coordinating corporate governance, contract negotiation, executive employment, and intellectual property issues, and helping international clients navigate US legal requirements as they enter or expand in the market.

He is known for an efficient, solutions-oriented approach – leading teams, anticipating risk, and driving negotiations towards practical outcomes that align with business goals. Earlier litigation experience in complex commercial and IP disputes informs his focus on structuring transactions that minimize downstream friction.

Client Work

  • Advised on multiple multi-billion-dollar acquisitions and sales involving pharmaceutical, medical device, diagnostic, and health care services businesses.
  • Represented sellers and buyers in the sale and carve-out of large contract development and manufacturing organizations (CDMOs) and drug-delivery platforms.
  • Advised on transactions involving generic and specialty pharmaceutical companies, including platform acquisitions and subsequent add-on strategies.
  • Represented both issuers and investors in venture and growth-stage financings, including preferred equity rounds, convertible notes, and SAFEs.
  • Counseled private equity sponsors and family offices in major platform investments and roll-up strategies in health care services, compliance, revenue-cycle management, and specialty pharmacy.
  • Advised on the sale of home-based senior care, hospice, and other provider-focused health care businesses, including complex multi-party mergers.
  • Represented owners of a national pharmaceutical distributor in a series of transactions culminating in a strategic sale to a public company.
  • Handled take-private and sponsor-led acquisitions of medical diagnostics and other health care-technology companies.
  • Advised on the sale of industrial, manufacturing, and packaging businesses, including carve-outs from large corporate groups.
  • Represented multinational companies in US acquisitions, divestitures, and investments across health care, industrials, and technology.
  • Advised in respect of strategic acquisitions of specialty insurance and risk management platforms.
  • Represented the seller in the sale of a national, multi-channel direct-to-consumer consumer products business.

Publications, Presentations & Recognitions

Publications

  • “As Our Heritage Crumbles to Dust: The Threat of State Law Protection for Pre-1972 Sound Recordings,” Wake Forest Intellectual Property Law Journal (2006)

Presentations

  • “Beyond Taxes: Securities Law Considerations for the Estate Planner,” IICLE 64th Annual Estate Planning Short Course, Webinar (May 25, 2021)

Recognitions

  • Illinois Rising Star, Illinois Super Lawyers, Thomson Reuters (2019-2021)
  • The Legal 500 United States – M&A/Corporate and Commercial: M&A – Middle-Market (Sub-$500m) (2019)
  • New York Metro Rising Star, New York Super Lawyers, Thomson Reuters (2013-2015)

Previous Work

  • Judicial Extern — Hon. John E. Ryan, U.S. Bankruptcy Court, Central District of California (2005)

Insights